Clinical Trial

Lower Silesia Cardiogenic Shock Initiative

Study acronym: LSCSI
Recruiting
View on ClinicalTrials.gov →
Summary
LSCSI is a Hub\&Spoke project with the main aim to improve the outcome of patients with cardiogenic shock in Lower Silesia region, Poland. It consists of one "hub" which is Wroclaw University Hospital and eleven "spokes" which are eleven cardiology departments situated in Lower Silesian Voivodeship. The consortium have unified protocol defining which cardiogenic shock patient and when should be transferred to the "hub" for enhanced treatment options including durable mechanical circulatory support or heart transplant. The "hub" have 7/24 Shock Team on-site supplied with a protocol how to proceed with "spoke" transferred patients including decision making on which mechanical circulatory support implant with subsequent de-escalation or escalation pathway.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-07-15; most recent amendment 2025-03-26.
Trial Details
NCT Number NCT05465200
Lead Sponsor Wroclaw Medical University
Conditions Cardiogenic Shock
Enrollment 50 participants
Start Date 2022-01-01
Primary Completion 2027-01-01 (estimated)
Study Completion 2028-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-02